A 52-year-old man with chronic pain on long-term morphine therapy presents to the emergency department with altered mental status, pinpoint pupils, and severe respiratory depression (RR 6/min, SpO₂ 78%). After securing the airway and initiating bag-mask ventilation, naloxone is administered intravenously. Which of the following statements regarding opioid toxicity and naloxone management is INCORRECT?

Explanation

## Naloxone Pharmacology and Opioid Overdose Management ### Mechanism and Selectivity of Naloxone **Key Point:** Naloxone is a **competitive antagonist** at opioid receptors, but it does NOT have equal affinity for all opioid receptor subtypes—it has highest affinity for mu (μ) receptors, moderate affinity for delta (δ) receptors, and lower affinity for kappa (κ) receptors. **High-Yield:** This differential receptor affinity has clinical implications: - Naloxone is highly effective for mu-receptor agonists (morphine, heroin, fentanyl, codeine) - Naloxone is less effective for kappa-receptor agonists (pentazocine, butorphanol) - Naloxone has variable efficacy for mixed agonist-antagonists (buprenorphine, tramadol) ### Comparison of Opioid Antagonists | Property | Naloxone | Naltrexone | Nalmefene | |----------|----------|-----------|----------| | **Receptor Selectivity** | μ > δ > κ (NOT equal) | μ > δ > κ | μ > δ > κ | | **Duration of Action** | 30–90 min (shorter than most opioids) | 24–72 hours | 8 hours | | **Route** | IV, IM, IN, SC | Oral, IM | IV, IM, SC | | **Clinical Use** | Acute overdose reversal | Chronic opioid dependence | Acute and chronic use | ### Why Statement 3 is Incorrect **Clinical Pearl:** The claim that naloxone is "non-selective" with "equal affinity for all opioid receptor subtypes" is false. Naloxone demonstrates **mu-receptor selectivity**, which is why: 1. It effectively reverses mu-agonist overdoses (morphine, fentanyl, heroin) 2. It is less effective for kappa-agonist overdoses (pentazocine, nalbuphine) 3. It has incomplete antagonism of buprenorphine (partial mu-agonist with high receptor binding affinity) **Warning:** Buprenorphine overdose may require higher naloxone doses or prolonged infusions due to buprenorphine's high mu-receptor binding affinity and partial agonist activity. ### Correct Statements Explained 1. **Duration mismatch:** Naloxone t½ = 30–90 min; morphine t½ = 2–4 hours. Repeated dosing or continuous infusion is mandatory to prevent recurrence. 2. **Withdrawal syndrome:** In opioid-dependent patients, naloxone precipitates acute withdrawal (agitation, tachycardia, diaphoresis, myalgias, lacrimation) by abruptly blocking mu-receptors. 3. **Titrated dosing:** Reversing only respiratory depression (not complete opioid effect) minimizes withdrawal severity while maintaining adequate ventilation. **Mnemonic:** **NARCAN** = **N**aloxone **A**ntagonizes **R**espiratory **C**ompromise **A**nd **N**eeds repeated dosing.